Valuation (36%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 51.63 | N/A |
| PEG Ratio (TTM) | 0.05 | N/A |
| P/S Ratio (TTM) | 3.32 | N/A |
| P/B Ratio (TTM) | 1.72 | N/A |
| P/FCF Ratio (TTM) | 24.60 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.88% | N/A |
| ROE (TTM) | 3.47% | N/A |
| Net Profit Margin (TTM) | 6.39% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 218.78% | 35.19% | N/A |
| Revenue | 3.26% | 24.46% | N/A |
| Net Income | 220.89% | 34.77% | N/A |
| Cash Flow | 612.47% | 677.27% | N/A |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.71 | N/A |
| Quick Ratio (TTM) | 3.71 | N/A |
| D/E Ratio (TTM) | 0.08 | N/A |
| Interest Coverage (TTM) | 7.37 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 7.51 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |